MedPath

Effect of folic acid, vitamin E, selenium on semen parameters

Not Applicable
Conditions
male infertility.
Azoospermia NOS - Oligospermia NOS
Registration Number
IRCT2017012432153N1
Lead Sponsor
Vice Chancellor for research of Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
Not specified
Inclusion Criteria

Tendency to participate in the study; Age range 25 to 54 years; Do not use of micronutrients out of study; Rejection of any obstructive disorder during radiological studies and anatomical examination; Abnormal parametres be approved by two semen analysis within two weeks
exclusion criteria: lake of Tendency to participate in the study; Azoospermia or Aspermia men; Men with sever varicocele; Recent urogenital infection that have been treated with antioxidants; History of allergic reactions to micronutrients; treated with the following drugs: sulfasalazine- methotrexate-Nitrofurantoin -colchicine –alpha blockers and cimetidine - spironolactone-antidepressants, beta-blocker-phenothiazine-metoclopramide-heroin- cocaine-cannabis-thiazide diuretic

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sperm morphology. Timepoint: Before intervention ninety days after intervention. Method of measurement: semenal analysis.;Sperm count. Timepoint: Before and ninety days after intervention. Method of measurement: semenal analysis.;Sperm motility. Timepoint: Before and ninety days after intervention. Method of measurement: semenal analysis.;White blood cell count. Timepoint: Before and ninety days after intervention. Method of measurement: semenal analysis.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath